Stryker Biotech
36 South St
Hopkinton
MA
01748
United States
(508) 416-5200
Product(s):
Develops bone morphogenic proteins to treat long-bone non-union breaks
Employees:
285
Established:
1989
Ownership:
Public
Exchange:
NYSE
symbol:
SYK
2004 Revenue:
$4,262,300,000
2005 Revenue:
$4,871,500,000
2006 Revenue:
$5,405,600,000
2007 Revenue:
$6,000,500,000
2008 Revenue:
$6,718,200,000
Yahoo Quotes:
Chairman:
Stephen P. MacMillan
President:
Stephen P. MacMillan
CEO:
Stephen P. MacMillan Management:
Dean H. Bergy, VP, CFO
Jeanne M. Blondia, VP, treasurer
Lonny Carpenter, president-instruments & medical
Andrew Fox-Smith, president-international
Curtis E. Hall, VP, general counsel
Curt Hartman, VP-finance
Stephen Si Johnson, VP, president-MedSurg
James E. Kemler, VP, president-biotech, osteosynthesis & development
Edward B. Lipes, EVP
Eric Lum, VP-Tax
Tony McKinney, VP, CAO
Katherine A. Owen, VP-strategy & investor relations
James B. Praeger, VP, controller
Michael W. Rude, VP-human resources
Tim Scannell, president-spine and endoscopy
Elizabeth A. Staub, VP-regulatory affairs & QA
Bronwen R. Taylor, VP-internal audit & compliance
Thomas R. Winkel, VP, secretary
Stryker Biotech
Printer-friendly versionPermalink
Similar entries
Top News Stories
RECENT BLOG POSTS
- Asian regulatory update: Hong Kong's hospitals to purchase new medical equipment
- Born to sell?
- Weekly Wireless Roundup: Monitor your baby with wireless pajamas
- Tips on "getting found" on LinkedIn
- Social media can be device makers' best friends
- MedGadget's MedTech Monday: Synthetic cornea offers performance on par with cadaver cornea after two years
- iConfess: Actions of a former brand skeptic
- What the heck is a medical device anyway?
- Weekly Wireless Roundup: GPS-enabled inhalers for rural sufferers of asthma
- MedGadget's MedTech Monday: Multicolor CT analysis of atherosclerotic plaque
Navigation
